アリゾナ州における転移性癌の臨床試験
アリゾナ州内の拠点で、転移性癌に関する46件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- CTCA at Western Regional Medical Center, Goodyear
- Kingman Regional Medical Center, Kingman
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- City of Hope, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
- Mayo Clinic in Arizona, Scottsdale
被験者募集中
15歳以上 · 全性別 · 2026/10/02更新 · NCT07856394A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- University of Arizona Cancer Center, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
- Mayo Clinic in Arizona, Scottsdale
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05222620PRE-ISPY Phase I/II Oncology Platform Program
- Mayo Clinic Comprehensive Cancer Center, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05868226Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Mayo Clinic Hospital, Phoenix
- The University of Arizona Cancer Center, Tucson
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06943755Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Ironwood Cancer & Research Centers, Chandler
- Banner MD Anderson Cancer Center, Gilbert
- Ironwood Cancer & Research Centers, Gilbert
- 他11件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Phoenix, Goodyear
- Mayo Clinic Arizona, Phoenix
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Pioneer Research Center, Bullhead City
- Ironwood Cancer & Research Centers, Chandler
- Ironwood Cancer & Research Centers, Gilbert
- 他6件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Mayo Clinic Hospital, Phoenix
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Mayo Clinic Building-Phoenix, Phoenix
- The University of Arizona Cancer Center - North Campus, Tucson
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07007559A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- The University of Arizona Cancer Center - North Campus, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Ironwood Cancer & Research Centers, Chandler
- Mayo Clinic in Arizona - Phoenix, Phoenix
- The University of Arizona Cancer Center - North Campus, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- HonorHealth, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
- Mayo Clinic Arizona, Phoenix
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07450859Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Mayo Clinic Building- Phoenix, Phoenix
- Mayo Clinic Arizona, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415CREO - Microwave Ablation Feasibility Study
- Banner MD Anderson Cancer Center and Gateway Hospital, Gilbert
被験者募集中
18歳以上 · 全性別 · 2026/09/14更新 · NCT07817147A Study of KK2269 in Adult Participants With Solid Tumors
- Mayo Clinic Arizona, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06266299A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Banner MD Anderson Cancer Center, Gilbert
- Banner University Medical Center Phoenix, Phoenix
- The University of Arizona Cancer Center - North Campus, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Gilbert
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Phoenix
- University of Arizona-Cancer Center, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06072612FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Arizona - Cancer Center, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Research Site, Scottsdale
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/08/18更新 · NCT06792695FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Mayo Clinic, Phoenix
- Honor Health, Scottsdale
- Arizona Cancer Center at University of Arizona, Tucson
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT07129252A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Mayo Clinic (Arizona), Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Tucson
被験者募集中第3相
18歳以上 · 女性 · 2026/07/29更新 · NCT07044336Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #108, Goodyear
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06545942Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #132, Phoenix
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06974110Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
- University of Arizona Cancer Center, Tucson
被験者募集中
18歳以上 · 全性別 · 2026/07/20更新 · NCT07415564A Study of PYX-201 in Advanced Solid Tumors
- HonorHealth Research Institute, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/30更新 · NCT05720117LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- Western Regional Medical Center, LLC, Goodyear
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/25更新 · NCT06216301First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07284186Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
- I-Mab Site 1016, Goodyear
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/14更新 · NCT07432295Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
- Dignity Health, Phoenix
被験者募集中
21歳以上 · 全性別 · 2026/05/12更新 · NCT06963723Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Ironwood Cancer & Research Centers, Chandler
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/05/08更新 · NCT06697301A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Banner MD Anderson Cancer Center, Gilbert
- The University of Arizona Cancer Center, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/09更新 · NCT06064877A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- HonorHealth Research Insisute, Scottsdale
被験者募集中第2/3相
全年齢 · 全性別 · 2026/04/02更新 · NCT06581406Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Mayo Clinic in Arizona, Phoenix
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/12更新 · NCT06349642ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。